v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Operating Activities          
Net loss     $ (48,646) $ (204,121)  
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation and amortization expense     13,487 13,171  
Amortization of debt issuance costs     2,196 1,414  
Provision for expected credit losses $ 1,901 $ 3,169 7,259 6,745  
Operating lease and other impairment charges     0 6,697  
Amortization of discount or (accretion of premium) on short-term investments     (2,748) (2,083)  
Loss from equity method investment 6,734 2,724 16,240 9,641  
Stock-based compensation expense     47,293 72,271  
Acquired in-process research and development expenses 0 0 0 75,217  
Other     3,353 1,041  
Changes in operating assets and liabilities:          
Accounts receivable, net     (24,587) (14,798)  
Inventories     (19,418) 17,252  
Prepaid and other current assets     (19,309) (12,140)  
Other long-term assets     (9,373) 3,585  
Accounts payable     26,115 (3,591)  
Employee-related liabilities     (6,026) 197  
Deferred revenue     (1,942) (4,102)  
Operating leases and other current liabilities     (3,000) 9,017  
Other long-term liabilities     (5,289) 5,077  
Net cash used in operating activities     (24,395) (19,510)  
Investing Activities          
Purchases of short-term investments     (290,478) (56,004)  
Proceeds from maturities and redemptions of short-term investments     122,111 200,583  
Purchases of property and equipment     (15,005) (13,263)  
Acquisition of in-process research and development     0 (43,464)  
Purchases of equity investments, strategic investments, and intangible assets     (81,427) 0  
Net cash provided by (used in) investing activities     (264,799) 87,852  
Financing Activities          
Proceeds from issuance of convertible senior notes due 2032, net of $8,843 debt issuance costs     291,157 0  
Principal payments on convertible senior notes due 2025     0 (40,760)  
Payment for capped call transactions related to convertible senior notes due 2032     (15,300) 0  
Principal payments on notes payable     (4,500) 0  
Cash used to settle withholding taxes on vested restricted stock, net of proceeds from issuance of common stock under Company stock plans     (2,075) (5,211)  
Net cash provided by (used in) financing activities     269,282 (45,971)  
Effect of foreign exchange rate changes on cash     2,118 342  
Net increase (decrease) in cash and cash equivalents     (17,794) 22,713  
Cash and cash equivalents at beginning of period     90,634 69,234 $ 69,234
Cash and cash equivalents at end of period $ 72,840 $ 91,947 72,840 91,947 $ 90,634
Supplemental disclosures of cash flow information          
Income taxes (refunded) paid     (1,338)    
Income taxes (refunded) paid       4,939  
Supplemental schedule of non-cash investing and financing activities          
Operating lease right-of-use assets obtained in exchange for operating lease obligations     10,224 26,169  
Purchases of property and equipment included in accounts payable and accrued expenses     2,039 830  
Intangible costs in other long-term liabilities     $ 0 $ 13,300